Quick Answer
BIOXYTRAN, INC reported Cash and Equivalents of $11.1 thousand for fiscal year 2016.
BIOXYTRAN, INC Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2016 | $11.1K | +218.6% |
| 2015 | $3.5K | -43.6% |
| 2014 | $6.2K | -70.2% |
| 2013 | $20.7K | +274.6% |
| 2012 | $5.5K | -66.6% |
| 2011 | $16.5K | -27.4% |
| 2010 | $22.8K | +297.3% |
| 2009 | $5.7K | — |
| 2008 | $0.00 | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2017 | $23.4K | +24.9% | +668.8% |
| March 31, 2017 | $3.0K | -67.7% | -72.5% |
| December 31, 2016 | $11.1K | +218.6% | -40.9% |
| September 30, 2016 | $18.8K | +61.2% | -17.3% |
| June 30, 2016 | $22.7K | +2826.5% | +140.4% |
| March 31, 2016 | $9.4K | +246.1% | +171.4% |
| December 31, 2015 | $3.5K | -43.6% | -70.1% |
| September 30, 2015 | $11.6K | -25.5% | +1400.9% |
- BIOXYTRAN, INC showed an increase of +218.6% in Cash and Equivalents compared to the prior fiscal year.
- The most recent figure is from BIOXYTRAN, INC’s fiscal year 2016 report (Form 10-K), filed with the SEC on March 31, 2017.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: